THE CLEVELAND CLINIC FOUNDATION has sponsored the creation of one or more 401k plans.
| Measure | Date | Value |
|---|
| 2018 : 2018 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
| Total transfer of assets to this plan | 2018-12-31 | $2,014,576,853 |
| Total transfer of assets from this plan | 2018-12-31 | $97,560,223 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Total income from all sources (including contributions) | 2018-12-31 | $-105,545,031 |
| Total loss/gain on sale of assets | 2018-12-31 | $-12,065 |
| Total of all expenses incurred | 2018-12-31 | $0 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $0 |
| Value of total assets at end of year | 2018-12-31 | $1,811,471,599 |
| Value of total assets at beginning of year | 2018-12-31 | $0 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $0 |
| Total interest from all sources | 2018-12-31 | $604,842 |
| Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $70,172,587 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $70,172,285 |
| Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
| Other income not declared elsewhere | 2018-12-31 | $3,247,865 |
| Total non interest bearing cash at end of year | 2018-12-31 | $38,987 |
| Total non interest bearing cash at beginning of year | 2018-12-31 | $0 |
| Value of net income/loss | 2018-12-31 | $-105,545,031 |
| Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $1,811,471,599 |
| Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $0 |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $1,625,885,431 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-12-31 | $42,034,764 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2018-12-31 | $604,842 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2018-12-31 | $143,357,726 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2018-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-179,558,260 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
| Income. Dividends from common stock | 2018-12-31 | $302 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2018-12-31 | $154,691 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2018-12-31 | $0 |
| Did the plan have assets held for investment | 2018-12-31 | Yes |
| Aggregate proceeds on sale of assets | 2018-12-31 | $114,318 |
| Aggregate carrying amount (costs) on sale of assets | 2018-12-31 | $126,383 |
